| P50 | author | Baozhong Wang | Q50995570 |
| | Richard W. Compans | Q45412816 |
| P2093 | author name string | Li Wang | |
| | Rui Xu | |
| | Sang-Moo Kang | |
| | Fu-Shi Quan | |
| P2860 | cites work | The evolution of human influenza viruses | Q24522380 |
| | Toll-like receptors | Q27860671 |
| | Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses | Q46737829 |
| | Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity. | Q50060542 |
| | Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection | Q50140873 |
| | Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo | Q56904232 |
| | Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants | Q73980726 |
| | Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility | Q28185475 |
| | Activation of interleukin-1 receptor-associated kinase by gram-negative flagellin | Q28201436 |
| | Regulation of interferon-gamma during innate and adaptive immune responses | Q28256001 |
| | Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine | Q30229190 |
| | Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function | Q30233581 |
| | Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection | Q30328172 |
| | Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. | Q30332972 |
| | Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. | Q30359424 |
| | Avian and pandemic influenza: an overview. | Q30359760 |
| | Influenza vaccine: the challenge of antigenic drift. | Q30363606 |
| | Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses. | Q30372024 |
| | MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization. | Q30382567 |
| | Advances in vaccine adjuvants | Q33764666 |
| | Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis | Q34334406 |
| | A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants | Q34678990 |
| | Induction of heterosubtypic immunity to influenza virus by intranasal immunization | Q34717084 |
| | Influenza vaccines: present and future | Q34717840 |
| | Enhancement of mucosal immunization with virus-like particles of simian immunodeficiency virus | Q34744920 |
| | Recent advances in mucosal vaccines and adjuvants | Q34786990 |
| | Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine. | Q35277985 |
| | Mucosal adjuvants | Q36055990 |
| | Mucosal vaccines: the promise and the challenge | Q36402244 |
| | Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B. | Q36464264 |
| | Implication of nanoparticles/microparticles in mucosal vaccine delivery | Q36837152 |
| | New horizon of mucosal immunity and vaccines | Q37506786 |
| | Immunological adjuvants: a role for liposomes | Q37922197 |
| | Design and delivery of non-parenteral vaccines. | Q38548249 |
| | Biodegradable microspheres in drug delivery | Q38565057 |
| | Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus | Q39584981 |
| | Hemagglutination-inhibition: rapid assay for neuraminic acid-containing viruses | Q40632706 |
| | Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes | Q40641430 |
| | Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses | Q40763973 |
| | Murine model for evaluation of protective immunity to influenza virus | Q45774092 |
| | Developments in mucosal influenza virus vaccines | Q45784050 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunization | Q1415366 |
| P304 | page(s) | e13972 | |
| P577 | publication date | 2010-11-29 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection | |
| P478 | volume | 5 | |